|Other Names||Mitotic spindle assembly checkpoint protein MAD2A, HsMAD2, Mitotic arrest deficient 2-like protein 1, MAD2-like protein 1, MAD2L1, MAD2|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13837c was selected from the Center region of MAD2L1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Component of the spindle-assembly checkpoint that prevents the onset of anaphase until all chromosomes are properly aligned at the metaphase plate. Required for the execution of the mitotic checkpoint which monitors the process of kinetochore- spindle attachment and inhibits the activity of the anaphase promoting complex by sequestering CDC20 until all chromosomes are aligned at the metaphase plate.|
|Cellular Location||Nucleus. Chromosome, centromere, kinetochore. Cytoplasm. Cytoplasm, cytoskeleton, spindle pole Note=Recruited by MAD1L1 to unattached kinetochores (Probable) Recruited to the nuclear pore complex by TPR during interphase Recruited to kinetochores in late prometaphase after BUB1, CENPF, BUB1B and CENPE. Kinetochore association requires the presence of NEK2. Kinetochore association is repressed by UBD.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
MAD2L1 is a component of the mitotic spindle assemblycheckpoint that prevents the onset of anaphase until allchromosomes are properly aligned at the metaphase plate. MAD2L1 isrelated to the MAD2L2 gene located on chromosome 1. A MAD2pseudogene has been mapped to chromosome 14.
Guo, Y., et al. J. Med. Genet. 47(9):616-622(2010)Hewitt, L., et al. J. Cell Biol. 190(1):25-34(2010)Kalsi, G., et al. Hum. Mol. Genet. 19(12):2497-2506(2010)Wang, L., et al. Tumour Biol. 31(3):225-232(2010)Gladhaug, I.P., et al. Histopathology 56(3):345-355(2010)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.